We use cookies on our website. Carry on browsing if you’re happy with this or find out more

Board of Directors


Catherine Moukheibir, MBA

Ms. Moukheibir is currently a non-executive director of Ironwood Pharmaceuticals Inc., GenKyoTex SA, Orphazyme A/S and non-executive Chair of MedDay Pharma SA. Ms. Moukheibir has held senior management positions at several European biotech companies after an initial career in strategy consulting and investment banking in Boston and London.

Previously she served as a non-executive director of Ablynx NV until its acquisition by Sanofi in 2018. She was the Senior Advisor, Finance and a member of the executive board of Innate Pharma SA from 2011 to 2016 and was Chief Financial Officer and a member of the executive committee of Movetis NV from 2008 until its acquisition by Shire plc in 2010. Ms. Moukheibir holds an MBA from Yale University.